238 related articles for article (PubMed ID: 12904334)
1. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo.
Lo AC; Saab CY; Black JA; Waxman SG
J Neurophysiol; 2003 Nov; 90(5):3566-71. PubMed ID: 12904334
[TBL] [Abstract][Full Text] [Related]
2. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
Black JA; Liu S; Hains BC; Saab CY; Waxman SG
Brain; 2006 Dec; 129(Pt 12):3196-208. PubMed ID: 16931536
[TBL] [Abstract][Full Text] [Related]
3. Sodium channel blockade with phenytoin protects spinal cord axons, enhances axonal conduction, and improves functional motor recovery after contusion SCI.
Hains BC; Saab CY; Lo AC; Waxman SG
Exp Neurol; 2004 Aug; 188(2):365-77. PubMed ID: 15246836
[TBL] [Abstract][Full Text] [Related]
4. Phenytoin protects central axons in experimental autoimmune encephalomyelitis.
Black JA; Waxman SG
J Neurol Sci; 2008 Nov; 274(1-2):57-63. PubMed ID: 18485368
[TBL] [Abstract][Full Text] [Related]
5. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
Craner MJ; Damarjian TG; Liu S; Hains BC; Lo AC; Black JA; Newcombe J; Cuzner ML; Waxman SG
Glia; 2005 Jan; 49(2):220-9. PubMed ID: 15390090
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis.
Brand-Schieber E; Werner P
Exp Neurol; 2004 Sep; 189(1):5-9. PubMed ID: 15296830
[TBL] [Abstract][Full Text] [Related]
7. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis.
Gresle MM; Shaw G; Jarrott B; Alexandrou EN; Friedhuber A; Kilpatrick TJ; Butzkueven H
J Neurosci Res; 2008 Dec; 86(16):3548-55. PubMed ID: 18709652
[TBL] [Abstract][Full Text] [Related]
8. Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine.
Black JA; Liu S; Carrithers M; Carrithers LM; Waxman SG
Ann Neurol; 2007 Jul; 62(1):21-33. PubMed ID: 17654737
[TBL] [Abstract][Full Text] [Related]
9. Restoration of conduction in the spinal roots correlates with clinical recovery from experimental autoimmune encephalomyelitis.
Chalk JB; McCombe PA; Pender MP
Muscle Nerve; 1995 Oct; 18(10):1093-100. PubMed ID: 7659103
[TBL] [Abstract][Full Text] [Related]
10. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
Papadopoulos D; Pham-Dinh D; Reynolds R
Exp Neurol; 2006 Feb; 197(2):373-85. PubMed ID: 16337942
[TBL] [Abstract][Full Text] [Related]
11. Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE.
Craner MJ; Hains BC; Lo AC; Black JA; Waxman SG
Brain; 2004 Feb; 127(Pt 2):294-303. PubMed ID: 14662515
[TBL] [Abstract][Full Text] [Related]
12. Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice.
Bannerman PG; Hahn A
J Neurol Sci; 2007 Sep; 260(1-2):23-32. PubMed ID: 17493638
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
Li FQ; Sempowski GD; McKenna SE; Laskowitz DT; Colton CA; Vitek MP
J Pharmacol Exp Ther; 2006 Sep; 318(3):956-65. PubMed ID: 16740622
[TBL] [Abstract][Full Text] [Related]
14. Detecting axon damage in spinal cord from a mouse model of multiple sclerosis.
Kim JH; Budde MD; Liang HF; Klein RS; Russell JH; Cross AH; Song SK
Neurobiol Dis; 2006 Mar; 21(3):626-32. PubMed ID: 16298135
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis.
Lo AC; Black JA; Waxman SG
Neuroreport; 2002 Oct; 13(15):1909-12. PubMed ID: 12395089
[TBL] [Abstract][Full Text] [Related]
16. 2-BFI attenuates experimental autoimmune encephalomyelitis-induced spinal cord injury with enhanced B-CK, CaATPase, but reduced calpain activity.
Wang P; Wang ZW; Lin FH; Han Z; Hou ST; Zheng RY
Biochem Biophys Res Commun; 2011 Mar; 406(1):152-7. PubMed ID: 21303658
[TBL] [Abstract][Full Text] [Related]
17. Tapered withdrawal of phenytoin removes protective effect in EAE without inflammatory rebound and mortality.
Liu S; Zwinger P; Black JA; Waxman SG
J Neurol Sci; 2014 Jun; 341(1-2):8-12. PubMed ID: 24690348
[TBL] [Abstract][Full Text] [Related]
18. Blockade of sodium channels by phenytoin protects ultrastructure and attenuates lipid peroxidation in experimental spinal cord injury.
Kaptanoglu E; Solaroglu I; Surucu HS; Akbiyik F; Beskonakli E
Acta Neurochir (Wien); 2005 Apr; 147(4):405-12; discussion 412. PubMed ID: 15696267
[TBL] [Abstract][Full Text] [Related]
19. Damage to bulbospinal serotonin-, tyrosine hydroxylase-, and TRH-containing axons occurs early in the development of experimental allergic encephalomyelitis in rats.
White SR; Samathanam GK; Bowker RM; Wessendorf MW
J Neurosci Res; 1990 Sep; 27(1):89-98. PubMed ID: 1701489
[TBL] [Abstract][Full Text] [Related]
20. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Truong JJ; Kerr BJ
Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
